Kaya Holdings, Inc.’s V.P. Bryan Arnold Among First Ten (10) State Licensed Psilocybin Facilitators in U.S.A.
Posted on Wednesday May 24, 2023

Kaya Holdings, Inc., ("KAYS" or the "Company") (OTCQB:KAYS), congratulates Bryan Arnold, a dedicated 9-year Kaya employee and Vice President with KAYS subsidiary Fifth Dimension Therapeutics, Inc. ("FDT"), for being among the first graduates of the Changa Institute and among the first ten (10) state Licensed Psilocybin Facilitators in the United States.

Kaya Holdings, Inc. Psychedelics Subsidiary Taps Total Holistic Center to Develop Ketamine Treatment Model for Launch of Fifth Dimension Therapeutics Mind Care Clinics
Posted on Wednesday February 15, 2023

Kaya Holdings, Inc., ("KAYS" or the "Company") (OTCQB:KAYS), a pioneer in the U.S. cannabis industry, announced today that its subsidiary Fifth Dimension Therapeutics™ (FDT) has reached an agreement in principle with Florida-based Total Holistic Center™ ("Total Holistic") to assist FDT with the development of its ketamine treatment model as a first step in the launch of its planned Fifth Dimension Therapeutics Mind Care Clinics and Telehealth Services.

Kaya Holdings, Inc. (OTCQB:KAYS) Launches Fifth Dimension Therapeutics(TM) to seek to Provide Innovative Psychedelic-Based Treatments for Depression and Anxiety Related Conditions and address the Growing Multi-Billion Dollar Global Psychedelics Market
Posted on Wednesday January 25, 2023

Kaya Holdings, Inc., ("KAYS" or the "Company") (OTCQB:KAYS), a pioneer in the U.S.

Kaya Holdings to Seek Licenses for First Ever State Legal Psilocybin Manufacturing and Facilitation Service Centers in Oregon
Posted on Wednesday August 03, 2022

Kaya Holdings, Inc., ("KAYS" or the "Company") (OTCQB:KAYS), the first U.S.